A consultation process over Australia’s Country of Origin labelling rules is underway – the guidelines which came under scrutiny after a leading brand was refused permission to use ‘Made in Australia’ claims for products using imported fish oil.
The US market for foods and beverages featuring hemp-derived CBD – from relaxation drinks to gummies – could be worth $2.5bn by 2023, or 10.5% of an estimated $23.7bn market for CBD products (spanning everything from pharmaceuticals to petfood), predicts...
An interim final rule on CBD is a viable way for FDA to break the logjam on this increasingly popular ingredient, according to the head of one industry trade organization.
China’s State Administration for Market Regulation (SAMR) is encouraging health food firms to contribute to the expansion of the Health Food Raw Materials Directory by presenting evidence to support the functional efficacy of ingredients to the unit.
Oregon Sen. Ron Wyden has put further pressure on FDA with a letter requesting a formal announcement of enforcement discretion on the CBD question while a more permanent regulatory solution is hashed out.
By the end of 2019, 98% of food and beverage products will have adopted a standardized version of date labeling – ‘Best If Used By' – with complete adoption anticipated by January 2020, predict the Grocery Manufacturers Association (GMA) and the...
There are several ingredient lists on FDA’s website that imply some sort of warning to the public. But what's the criteria that decides into which list an ingredient will fall?
An amendment advocated by the Natural Products Association that would earmark funds for CBD regulation was including in the final version of the 2019 appropriations bill passed by the US House of Representatives.
Natural products online marketplace Thrive Market has temporarily halted sales of hemp-derived CBD products after its merchant processor demanded it cease selling them amid uncertainty over their legal status, but says it is in conversations with a new...
The US Food and Drug Administration has approved a list of qualified health claims for omega-3 fatty acids and their effect on blood pressure, culminating a five year plus effort on the part of industry.
An amendment to the National Defense Authorization Act (NDAA) introduced to Congress would require the creation of a reporting system for adverse events that may be associated with dietary supplements use in the military. Trade group CRN is pushing back,...
Congress should act to create a new law to solve the CBD (cannabidiol) regulatory issue, while simultaneously “closing long-standing gaps” in the oversight of all dietary supplements, according to a new paper by Dr Pieter Cohen and Dr Joshua Sharfstein.
